Favourable ruling for generic Yaz in US court, says Lupin

A US court has ruled in Lupin's favour paving the way for the company to introduce a generic version of Bayer AG's Yaz tablets in the American market, the drug major said in a statement on Wednesday. "The US Court of Appeals for the Federal Circuit has ruled in the company's favour regarding its appeal of a previous judgement by a lower court for Bayer AG's Yaz oral contraceptive product," the statement said. On April 16, 2...